Effect of Hypertension and Hypertension-Glucose Intolerance on Myocardial Ischemic Injury

Hypertension

Volumn 42, Issue 5, 2003, Pages 1042-1049

  Mozaffari, Mahmood S ^a   Schaffer, Stephen W ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Glucose; Hypertension, chronic; Myocardial contraction; Myocardial infarction

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CELL DEATH; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GLUCOSE INTOLERANCE; HEART AFTERLOAD; HEART HYPERTROPHY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; HEART VENTRICLE PRESSURE; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; LEFT CORONARY ARTERY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR;

ANIMALS; GLUCOSE INTOLERANCE; HEART; HYPERTENSION; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; ORGAN CULTURE TECHNIQUES; RATS; RATS, INBRED WKY;

EID: 0242441468     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000095614.91961.40     Document Type: Article

References (42)

1. Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med. 1997;126:296-306.
2. Abenavoli T, Rubler S, Fisher VJ, Axelrod HI, Zuckerman KP. Exercise testing with myocardial scintigraphy in asymptomatic diabetic males. Circulation. 1981;63:54-64.
3. Feuvray D, Lopaschuk GD. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res. 1997;34:113-120.
4. Paulson DJ. The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res. 1997;34:104-112.
5. Maddaford TG, Russell JC, Pierce GN. Postischemic cardiac performance in the insulin-resistant JCR:LA-cp rat. Am J Physiol. 1997;273: H1187-H1192.
6. Snoeckx LH, van der Vusse GJ, Coumans WA, Reneman RS. The effects of global ischemia and reperfusion on compensated hypertrophied rat hearts. J Mol Cell Cardiol. 1990;22:1439-1452.
7. Lee YM, Peng YY, Ding YA, Yen MH. Losartan attenuates myocardial ischemia-induced ventricular arrhythmias and reperfusion injury in spontaneously hypertensive rats. Am J Hypertens. 1997;10:852-858.
8. 2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts. Circulation. 1996;94:3087-3089.
9. Chen H, Higashino H, Maeda K, Zhang Z, Ohta Y, Wang Z, Su DF, Yuan WJ. Reduction of cardiac norepinephrine improves postischemic heart function in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol. 2001;38:821-832.
10. Siri FM, Malhotra A, Factor SM, Sonnenblick EH, Fein FS. Prolonged ejection duration helps to maintain pump performance of the renal-hypertensive-diabetic rat heart: correlations between isolated papillary muscle function and ventricular performance in situ. Cardiovasc Res. 1997;34:230-240.
11. Rodrigues B, McNeill JH. Cardiac function in spontaneously hypertensive diabetic rats. Am J Physiol. 1986;251:H571-H580.
12. Wold LE, Relling DP, Colligan PB, Scott GI, Hintz KK, Ren BH, Epstein PN, Ren J. Characterization of contractile function in diabetic hypertensive cardiomyopathy in adult rat ventricular myocytes. J Mol Cell Cardiol. 2001;33:1719-1726.
13. Mozaffari MS, Patel C, Warren BK, Schaffer SW. NaCl-induced hypertensive rat model of non-insulin-dependent diabetes: role of sympathetic modulation. Am J Hypertens. 2000;13:540-546.
14. Mozaffari MS, Schaffer SW. Impaired saline-stimulated diuresis and natriuresis in the conscious hypertensive-glucose intolerant rat. Am J Hypertens. 2002;15:58-65.
15. Schaffer SW, Mozaffari MS. The neonatal STZ model of diabetes. In: McNeil JH, ed. Experimental Models of Diabetes. Boca Raton, Fla: CRC Press; 1999:231-255.
16. Liu Y, Thornton JD, Cohen MV, Downey JM, Schaffer SW. Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation. 1993;88:1273-1278.
17. Schaffer SW, Mozaffari MS, Artman M, Wilson GL. Basis for myocardial mechanical defects associated with non-insulin-dependent diabetes. Am J Physiol. 1989;256:E25-E30.
18. Mozaffari MS, Patel K, Schaffer SW. Renoprotective effects of chronic candesartan treatment in the uninephrectomized rat. J Cardiovasc Pharmacol. 2003;41:81-88.
19. Mozaffari MS, Wyss JM. Dietary NaCl-induced hypertension in uninephrectomized Wistar-Kyoto rats: role of kidney function. J Cardiovasc Pharmacol. 1999;33:814-821.
20. Yamamoto J, Nakai M. Effects of moderate diabetes on cardiac performance in spontaneously hypertensive and Wistar Kyoto rats. Hypertension. 1988;11:344-351.
21. Mathis DR, Liu SS, Rodrigues BB, McNeill JH. Effect of hypertension on the development of diabetic cardiomyopathy. Can J Physiol Pharmacol. 2000;78:791-798.
22. Goel DP, Pierce GN. Role of the sodium-hydrogen exchanger in ischemia-reperfusion injury in diabetes. J Thromb Thrombolysis. 1999;8:45-52.
23. Schaffer SW, Croft CB, Solodushko V. Cardioprotective effect of chronic hyperglycemia: effect on hypoxia-induced apoptosis and necrosis. Am J Physiol. 2000;278:H1948-H1954.
24. Snoeckx LH, van der Vusse GJ, Coumans WA, Willemsen PH, Reneman RS. Differences in ischaemia tolerance between hypertrophied hearts of adult and aged spontaneously hypertensive rats. Cardiovasc Res. 1993;27:874-881.
25. Pijl AJ, Hendriks MG, Kam KL, Pfaffendorf M, van Zwieten PA. Antiischemic effects of nifedipine in isolated working heart preparations of healthy, diabetic, and hypertensive rats. J Cardiovasc Pharmacol. 1994;23:379-386.
26. Leenen FH, Yuan B. Mortality after coronary artery occlusion in different models of cardiac hypertrophy in rats. Hypertension. 2001;37:209-215.
27. Koyanagi S, Eastham CL, Harrison DG, Marcus ML. Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy. Circ Res. 1982;50:55-62.
28. Bolli R, Kuo LC, Roberts R. Influence of acute arterial hypertension on myocardial infarct size in dogs with left ventricular hypertrophy. J Am Coll Cardiol. 1984;4:522-528.
29. Inou T, Lamberth WC Jr, Koyanagi S, Harrison DG, Eastham CL, Marcus ML. Relative importance of hypertension after coronary occlusion in chronic hypertensive dogs with LVH. Am J Physiol. 1987;253: H1148-H1158.
30. Speechly-Dick ME, Baxter GF, Yellon DM. Ischaemic preconditioning protects hypertrophied myocardium. Cardiovasc Res. 1994;28:1025-1029.
31. Joyeux M, Lagneux C, Bricca G, Yellon DM, Demenge P, Ribuot C. Heat stress-induced resistance to myocardial infarction in the isolated heart from transgenic [(mREN-2)27] hypertensive rats. Cardiovasc Res. 1998;40:124-130.
32. Nishikimi T, Yamagishi H, Takeuchi K, Takeda T. An angiotensin II receptor antagonist attenuates left ventricular dilatation after myocardial infarction in the hypertensive rat. Cardiovasc Res. 1995;29:856-861.
33. Schaffer S, Takahashi K, Azuma J. Role of osmoregulation in the actions of taurine. Amino Acids. 2000;19:527-546.
34. De Petris L, Luchetti A, Emma F. Cell volume regulation and transport mechanisms across the blood-brain barrier: implications for the management of hypernatraemic states. Eur J Pediatr. 2001;160:71-77.
35. Ovize M, Kloner RA, Przyklenk K. Stretch preconditions canine myocardium. Am J Physiol. 1994;266:H137-H146.
36. Schulz R, Cohen MV, Behrends M, Downey JM, Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc Res. 2001;52:181-198.
37. i in isolated guinea-pig ventricular myocytes. Cardiovasc Res. 1996;32:158-167.
38. Yamazaki T, Komuro I, Kudoh S, Zou Y, Nagai R, Aikawa R, Uozumi H, Yazaki Y. Role of ion channels and exchanger in mechanical stretch-induced cardiomyocyte hypertrophy. Circ Res. 1998;82:430-437.
39. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P. Stretch-induced programmed myocyte cell death. J Clin Invest. 1995;96:2247-2259.
40. Pham I, Gonzalez W, el Amrani AIK, Fournie-Zaluski MC, Philippe M, Laboulandine I, Roques BP, Michel JB. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension. J Pharmacol Exp Ther. 1993;265:1339-1347.
41. 1-adrenoceptors? Chest. 2001;119:1242-1249.
42. Itano Y, Ito A, Uehara T, Nomura Y. Regulation of Bcl-2 protein expression in human neuroblastoma SH-SY5Y cells: positive and negative effects of protein kinases C and A, respectively. J Neurochem. 1996;67:131-137.